36. Dare to Care: The Future of Women's Sexual Health

Why do men get decades of sexual-health innovation while women are still told to wait, cope, or buy something vaguely "wellness-adjacent" from their social media feed? And why are conditions that affect quality of life, relationships, pleasure, and reproductive health still treated like optional extras instead of actual healthcare?

Sabrina Martucci Johnson, founder and CEO of Daré Bioscience, joins this episode of Labia Logic to talk about the costly, complicated, and long-overdue work of developing better treatments for women. Sabrina explains why she founded Daré, how women's health receives only a fraction of private healthcare investment, and why existing science can often be reformulated into solutions designed specifically for female bodies.

Sabrina also shares what Daré is developing next, including a monthly vaginal ring for menopause hormone therapy, a hormone-free contraceptive, and a vaginal antiviral treatment for high-risk HPV.

Because women's health is not niche. It is essential, overdue, and worth doing right.

Links:

darebioscience.com

Instagram @darebioscience

TikTok @sabrinadareceo

LinkedIn @sabrina-martucci-johnson

About Our Guest:

Sabrina Martucci Johnson doesn't just talk about the gap in women's health – she's working to close it. In 2015 she founded Daré Bioscience on a straightforward thesis: the science exists, the need is real, and the market is massive. What's been missing is execution.

Under her leadership, Daré has built a pipeline of first-in-category product candidates spanning contraception, sexual health, menopause, vaginal health, and infectious disease, and is now bringing them to market.